More about
Cutaneous Graft-Versus-Host Disease
CME
Video
Preventing and Treating Acute GvHD: A Discussion of Real-World Cases
Supported by an independent educational grant from CSL Behring LLC.
News
February 27, 2024
3 min read
Save
Ruxolitinib cream ‘effective’ in reducing rashes, lesions caused by cutaneous GVHD
Topical ruxolitinib cream significantly reduced skin manifestations caused by cutaneous graft-versus-host disease compared with vehicle cream, results from a randomized phase 2 study showed.